Literature DB >> 7978797

Plasma assay of matrix metalloproteinases (MMPs) and MMP-inhibitor complexes in cancer. Potential use in predicting metastasis and monitoring treatment.

S Zucker1, R M Lysik, H M Zarrabi, U Moll, S P Tickle, W Stetler-Stevenson, T S Baker, A J Docherty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7978797     DOI： 10.1111/j.1749-6632.1994.tb24740.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

Review 1.  A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma.

Authors:  L Yan; M A Moses
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

Review 2.  Matrix metalloproteinase inhibitors.

Authors:  S M Wojtowicz-Praga; R B Dickson; M J Hawkins
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

3.  Golgi phosphoprotein 3 regulates metastasis of prostate cancer via matrix metalloproteinase 9.

Authors:  Wenzhi Li; Kai Qi; Zhanyu Wang; Meng Gu; Gang Chen; Fengfu Guo; Zhong Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

Review 4.  MMP induction and inhibition in myocardial infarction.

Authors:  Merry L Lindsey
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

Review 5.  Matrix metalloproteinases and myocardial infarction.

Authors:  Wannakorn Phatharajaree; Arintaya Phrommintikul; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2007-07       Impact factor: 5.223

6.  Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt.

Authors:  Amani Ahmed Alrehaili; Amal Fathi Gharib; Rehab Ahmed Karam; Reem Ali Alhakami; Wael Hassan El Sawy; Tamer Mohamed Abd Elrahman
Journal:  Mol Biol Rep       Date:  2019-12-09       Impact factor: 2.316
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.